Zomedica Corp. (ZOMDF)

Zomedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.28	9.02	7.02	12.95	27.4	194.95
Short-Term Investments	32.85	44.24	64.33	77.55	87.69	-
Cash & Short-Term Investments	40.13	53.26	71.35	90.5	115.09	194.95
Cash Growth	-24.47%	-25.36%	-21.15%	-21.37%	-40.96%	214.48%
Accounts Receivable	6.79	3.01	2.42	1.2	0.6	0.32
Other Receivables	0.39	0.44	0.65	1	1.27	0.45
Receivables	7.18	3.46	3.07	2.2	1.86	0.77
Inventory	5.77	5.55	5.06	5.12	2.75	2.85
Prepaid Expenses	2.36	1.79	2.29	2.06	3.8	1.84
Total Current Assets	55.44	64.04	81.77	99.88	123.5	200.41
Property, Plant & Equipment	21.09	22.94	26.2	25.29	9.17	2.87
Long-Term Investments	0.75	-	-	10.01	40.71	-
Goodwill	-	-	45.56	61.58	63.98	43.29
Other Intangible Assets	36.65	38.81	52.54	55.36	41.8	33.18
Other Long-Term Assets	1.1	1.25	1.29	1.07	0.45	0.66
Total Assets	115.03	127.04	207.36	253.2	279.61	280.4

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.1	1.72	1.93	2.07	6.7	3.23
Accrued Expenses	5.47	6.2	6.1	5.35	-	-
Current Portion of Leases	0.73	0.72	0.52	0.92	0.64	0.42
Current Income Taxes Payable	0.22	0.25	0.12	0.07	0.19	0.24
Current Unearned Revenue	0.39	0.37	0.33	0.28	0.21	0.2
Other Current Liabilities	0.19	0.2	0.34	0.36	0.08	0.26
Total Current Liabilities	9.1	9.45	9.33	9.03	7.81	4.34
Long-Term Leases	0.92	1.47	1.29	1.81	1.1	0.96
Long-Term Unearned Revenue	0.3	0.23	0.22	0.25	0.18	0.14
Long-Term Deferred Tax Liabilities	0.03	0.03	0.46	1.14	1.25	3.71
Other Long-Term Liabilities	0.39	0.47	0.4	0.94	1.88	0.36
Total Liabilities	10.74	11.64	11.7	13.18	12.22	9.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	380.97	380.97	380.97	380.97	380.97	380.96
Additional Paid-In Capital	34.47	34.04	32.52	29.93	23.67	9.31
Retained Earnings	-311.24	-299.77	-217.92	-170.93	-136.4	-119.39
Comprehensive Income & Other	0.08	0.16	0.09	0.05	-0.84	0
Total Common Equity	104.28	115.4	195.66	240.02	267.39	270.89
Shareholders' Equity	104.28	115.4	195.66	240.02	267.39	270.89
Total Liabilities & Equity	115.03	127.04	207.36	253.2	279.61	280.4

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.65	2.18	1.81	2.73	1.74	1.38
Net Cash (Debt)	38.48	51.07	69.54	87.77	113.35	193.57
Net Cash Growth	-24.21%	-26.56%	-20.77%	-22.57%	-41.44%	221.96%
Net Cash Per Share	0.04	0.05	0.07	0.09	0.12	0.20
Filing Date Shares Outstanding	979.95	979.95	979.95	979.95	979.95	979.9
Total Common Shares Outstanding	979.95	979.95	979.95	979.95	979.95	979.9
Working Capital	46.34	54.59	72.44	90.85	115.69	196.07
Book Value Per Share	0.11	0.12	0.20	0.24	0.27	0.28
Tangible Book Value	67.63	76.59	97.57	123.07	161.61	194.42
Tangible Book Value Per Share	0.07	0.08	0.10	0.13	0.16	0.20
Machinery	17.32	16.57	17.03	10.44	6.85	1.73
Construction In Progress	5.82	6.42	7.89	12.48	0.69	0.42
Leasehold Improvements	2.87	2.85	3.09	1.95	1.24	0.29

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error